Olgu Sunumu

Ertapenem tedavisine bağlı gelişen deliryum ve tremor

Cilt: 57 Sayı: 1 1 Mart 2018
PDF İndir
EN TR

Delirium and tremor associated with ertapenem treatment

Abstract

Though seizures are the most commonly reported neurotoxic adverse effects of ertapenem, there are numerous other side effects including hallucinations, disorientation, and tremors which are hardly ever reported. These side effects can be life-threatening, in the case of continued use of ertapenem. However, these treatment-related side effects completely resolve with discontinuation of the treatment. A 60-year-old female patient underwent hemodialysis owing to acute kidney insufficiency. Ertapenem was used to treat the condition since cultures from blood and urine sample of the patient showed growth of extended-spectrum beta-lactamase positive Escherichia coli. It was seen that the patient experienced tremors in the hand on the sixth day of the treatment, and hallucinations, disorientation, aggression, impaired speech as well as gait disturbances on the eighth day. With the discontinuation of ertapenem treatment, all these symptoms disappeared within 72 hours. This paper emphasizes on the neurotoxicity other than seizures resulting from ertapenem.

Keywords

Kaynakça

  1. Oo Y, Packham D, Yau W, Munckhof WJ. Ertapenem‐associated psychosis and encephalopathy. Int Med J 2014:44(8);817-9.
  2. Apodaca K, Baker, Bin-Bilal H, Raskin Y, Quinn DK. Ertapenem-induced delirium: A case report and literature review. Psychosomatics 2015:56(5);561-6.
  3. Ribo FZ, Ribo AA. Ertapenem-induced neuropsychiatric symptoms in an elderly patient with chronic kidney disease resulting to a prescribing cascade. J Pharmacovigil 2014;2(6):152.
  4. Duquaine S, Kitchell E, Tate T, Tannen RC, Wickremasinghe IM. Central nervous system toxicity associated with ertapenem use. Ann Pharmacother 2011:45(1):e6.
  5. Veillette JJ, Van Epps P. Ertapenem-induced hallucinations and delirium in an elderly patient. Consult Pharm 2016:31(4);207-14.
  6. Lee KH, Ueng YF, Wu CW, Chou YC, Ng YY, Yang WC. The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients–case reports and literature reviews. J Clin Pharm Ther 2015:40(2); 240-4.
  7. Shea YF, Mok MYM, Cheng KC, Hon FKS, Chu LW. Delayed recovery from ertapenem induced encephalopathy: Case report and a possible mechanism. Int J Clin Pharm 2013:35(4);535-7.
  8. Kong V, Beckert L, Awunor-Renner C. A case of beta lactam–induced visual hallucination. N Z Med J 2009;122(1298):76-7.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

Olgu Sunumu

Yazarlar

Fatih Temoçin
0000-0002-4819-8242
Türkiye

Yayımlanma Tarihi

1 Mart 2018

Gönderilme Tarihi

19 Şubat 2017

Kabul Tarihi

24 Nisan 2017

Yayımlandığı Sayı

Yıl 1970 Cilt: 57 Sayı: 1

Kaynak Göster

Vancouver
1.Hatice Köse, Fatih Temoçin. Delirium and tremor associated with ertapenem treatment. ETD. 01 Mart 2018;57(1):60-3. doi:10.19161/etd.414446

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.